KERYX BIOPHARMACEUTICALS INC

CUSIP: 492515101 Class: COMMON STOCK

LINCOLN CAPITAL CORP's Holding History (CIK: 0000872359)

Note: Option positions (PUT/CALL) are excluded.

Q3 2018
Shares 37,280 Value ($000) $127 Avg Close — Range —
Q2 2018
Shares 65,800 Value ($000) $247 Avg Close — Range —
Q1 2018
Shares 67,910 Value ($000) $278 Avg Close — Range —
Q4 2017
Shares 66,910 Value ($000) $311 Avg Close — Range —
Q3 2017
Shares 36,500 Value ($000) $259 Avg Close — Range —
Q2 2017
Shares 36,500 Value ($000) $264 Avg Close — Range —
Q1 2017
Shares 30,300 Value ($000) $187 Avg Close — Range —
Q4 2016
Shares 26,800 Value ($000) $158 Avg Close — Range —